DLeader Founded in Osaka to Advance AI-Driven Drug Discovery

DLeader, Inc. was founded in Osaka, Japan, on April 12, 2024, with Dr. Qingwen Chen as Founder & CEO.

Established with a vision to expand the possibilities of drug discovery through AI, DLeader aims to develop intelligent tools that help researchers design better therapeutic candidates and make informed decisions more efficiently. The company’s ambition is to accelerate the path from scientific discovery to new treatments and contribute to broader therapeutic options for patients.